Environmental research · 2025
Associations of urinary N, N-dimethylformamide metabolite concentrations with ovarian reserve and in vitro fertilization outcomes based on a prospective cohort study in China.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Luo Xiao, Qian Xi, Duan Yalin, Luo Li, Li Ruijia, Xiao Wang, Zhang Qi, Zhang Xiaodong, Guo Xiaoni, Liao Haiyuan, Wang Qi, Huang Guoning, Wan Yanjian
Аннотация
BACKGROUND: N,N-Dimethylformamide (DMF) is a recognized reproductive toxicant based on animal studies and male occupational epidemiological data. However, no studies have investigated the association of DMF exposure with ovarian reserve or in vitro fertilization (IVF) outcomes in women.
OBJECTIVES: To explore the relationship of DMF exposure with ovarian reserve and IVF outcomes in women undergoing IVF treatment.
METHODS: This study included 737 women undergoing IVF treatment in Chongqing, China, between February and October 2023. One follicular fluid (FF) and three urine samples were prospectively collected from each participant, and the primary metabolite of DMF, N-acetyl-S-(N-methylcarbamoyl)-L-cysteine (AMCC), was measured. Associations between AMCC levels and ovarian reserve or IVF outcomes were assessed using generalized linear models and generalized estimating equations models.
RESULTS: AMCC (median: 57.4 ng/mL) was detected in over 99% of the urine samples across the three visits, but was undetectable in all the FF samples. Higher urinary AMCC concentrations were associated with several outcomes after adjustment for body mass index, age, ethnicity, smoking status, and reasons for infertility. For example, an interquartile range-fold increase in AMCC at the first visit was associated with higher basal serum estradiol levels (10.1% increase; 95% CI: 4.01-16.6%) but lower oocyte yield (3.24% decrease; 95% CI: -6.20 to -0.19%), mature oocytes (3.41% decrease; 95 %CI: -6.64 to -0.07%), and the proportion of day 3 good-quality embryos [rate ratio (RR): 0.87; 95% CI: 0.79 to 0.96]. Similarly, an interquartile range-fold increase in geometric mean urinary AMCC concentrations across the three visits was associated with decreases in the proportions of day 3 good-quality embryos (RR: 0.82; 95% CI: 0.74 to 0.92) and usable blastocysts (RR: 0.93; 95% CI: 0.87 to 0.999).
DISCUSSION: Urinary AMCC was positively associated with basal serum estradiol but negatively associated with the number of total and mature oocytes, and the proportions of day 3 good-quality embryos and usable blastocysts. Reducing AMCC-related exposure may help protect female reproductive capacity.
OBJECTIVES: To explore the relationship of DMF exposure with ovarian reserve and IVF outcomes in women undergoing IVF treatment.
METHODS: This study included 737 women undergoing IVF treatment in Chongqing, China, between February and October 2023. One follicular fluid (FF) and three urine samples were prospectively collected from each participant, and the primary metabolite of DMF, N-acetyl-S-(N-methylcarbamoyl)-L-cysteine (AMCC), was measured. Associations between AMCC levels and ovarian reserve or IVF outcomes were assessed using generalized linear models and generalized estimating equations models.
RESULTS: AMCC (median: 57.4 ng/mL) was detected in over 99% of the urine samples across the three visits, but was undetectable in all the FF samples. Higher urinary AMCC concentrations were associated with several outcomes after adjustment for body mass index, age, ethnicity, smoking status, and reasons for infertility. For example, an interquartile range-fold increase in AMCC at the first visit was associated with higher basal serum estradiol levels (10.1% increase; 95% CI: 4.01-16.6%) but lower oocyte yield (3.24% decrease; 95% CI: -6.20 to -0.19%), mature oocytes (3.41% decrease; 95 %CI: -6.64 to -0.07%), and the proportion of day 3 good-quality embryos [rate ratio (RR): 0.87; 95% CI: 0.79 to 0.96]. Similarly, an interquartile range-fold increase in geometric mean urinary AMCC concentrations across the three visits was associated with decreases in the proportions of day 3 good-quality embryos (RR: 0.82; 95% CI: 0.74 to 0.92) and usable blastocysts (RR: 0.93; 95% CI: 0.87 to 0.999).
DISCUSSION: Urinary AMCC was positively associated with basal serum estradiol but negatively associated with the number of total and mature oocytes, and the proportions of day 3 good-quality embryos and usable blastocysts. Reducing AMCC-related exposure may help protect female reproductive capacity.